Suppr超能文献

肾移植术后前6个月的尿路感染

Urinary Tract Infections in the First 6 Months after Renal Transplantation.

作者信息

Arabi Ziad, Al Thiab Khalefa, Altheaby Abdulrahman, Aboalsamh Ghaleb, Kashkoush Samy, Almarastani Mohamad, Shaheen Mohammed F, Altamimi Abdulrahman, O'hali Wael, Bin Saad Khalid, Alnajjar Lina, Alhussein Rawan, Almuhiteb Raghad, Alqahtani Bashayr, Alotaibi Rayana, Alqahtani Marah, Tawhari Mohammed

机构信息

Division of Adult Transplant Nephrology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.

King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.

出版信息

Int J Nephrol. 2021 Nov 15;2021:3033276. doi: 10.1155/2021/3033276. eCollection 2021.

Abstract

PURPOSE

Urinary tract infections (UTIs) are common in the first 6 months after renal transplantation, and there are only limited data about UTIs after transplantation in Saudi Arabia in general.

METHODS

A retrospective study from January 2017 to May 2020 with 6-month follow-up.

RESULTS

279 renal transplant recipients were included. Mean age was 43.4 ± 16.0 years, and114 (40.9%) were women. Urinary stents were inserted routinely during transplantation and were removed 35.3 ± 28 days postoperatively. Ninety-seven patients (35%) developed urinary tract infections (UTIs) in the first six months after renal transplantation. Of those who developed the first episode of UTI, the recurrence rates were 57%, 27%, and 14% for having one, two, or three recurrences, respectively. Late urinary stent removals, defined as more than 21 days postoperatively, tended to have more UTIs (OR: 1.43, P: 0.259, CI: 0.76-2.66). Age >40, female gender, history of neurogenic bladder, and transplantation abroad were statistically significant factors associated with UTIs and recurrence. Diabetes, level of immunosuppression, deceased donor renal transplantation, pretransplant residual urine volume, or history of vesicoureteral reflux (VUR) was not associated with a higher incidence of UTIs. UTIs were asymptomatic in 60% but complicated with bacteremia in 6% of the cases. Multidrug resistant organisms (MDROs) were the causative organisms in 42% of cases, and in-hospital treatment was required in about 50% of cases. Norfloxacin + Bactrim DD (160/800 mg) every other day was not associated with the lower risk of developing UTIs compared to the standard prophylaxis daily Bactrim SS (80/400 mg).

CONCLUSION

UTIs and recurrence are common in the first 6 months after renal transplantation. Age >40, female gender, neurogenic bladder, and transplantation abroad are associated with the increased risk of UTIs and recurrence. MDROs are common causative organisms, and hospitalization is frequently required. Dual prophylactic antibiotics did not seem to be advantageous over the standard daily Bactrim.

摘要

目的

尿路感染(UTIs)在肾移植后的前6个月很常见,而关于沙特阿拉伯总体肾移植后尿路感染的数据有限。

方法

一项回顾性研究,时间跨度为2017年1月至2020年5月,并进行6个月的随访。

结果

纳入279例肾移植受者。平均年龄为43.4±16.0岁,女性114例(40.9%)。移植期间常规插入输尿管支架,并在术后35.3±28天取出。97例患者(35%)在肾移植后的前6个月发生了尿路感染(UTIs)。在发生首次UTI的患者中,复发率分别为:复发一次的患者为57%,复发两次的患者为27%,复发三次的患者为14%。术后超过21天取出输尿管支架(定义为晚期取出)的患者往往发生更多的UTIs(比值比:1.43,P值:0.259,可信区间:0.76 - 2.66)。年龄>40岁、女性、神经源性膀胱病史以及在国外进行移植是与UTIs及其复发相关的具有统计学意义的因素。糖尿病、免疫抑制水平、已故供体肾移植、移植前残余尿量或膀胱输尿管反流(VUR)病史与UTIs的较高发生率无关。60%的UTIs患者无症状,但6%的病例并发菌血症。42%的病例中多重耐药菌(MDROs)是致病菌,约50%的病例需要住院治疗。与标准每日服用复方新诺明(80/400mg)预防相比,隔天服用诺氟沙星+复方新诺明双倍剂量(160/800mg)与发生UTIs的较低风险无关。

结论

UTIs及其复发在肾移植后的前6个月很常见。年龄>40岁、女性、神经源性膀胱以及在国外进行移植与UTIs及其复发风险增加相关。MDROs是常见的致病菌,且经常需要住院治疗。双联预防性抗生素似乎并不比标准每日服用复方新诺明更具优势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/289e/8608522/1a6260814f84/IJN2021-3033276.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验